Updates
GENEGUT Behind the Scenes: Bangor University
Welcome to the first edition of our “GENEGUT: Behind the Scenes” campaign — a series that shines a light on the dedicated teams behind GENEGUT. Each article features one of our partners and showcases their unique role, contributions, and passion driving this EU-funded project forward.
GENEGUT Synergies: Collaboration across GENEGUT partners advances development of RNA-based nanoparticles for oral delivery to treat Crohn’s disease
Collaboration between partners at Cork University and Uppsala University has resulted in a robust system to investigate the interactions between the NPs formulated and 3D ileal organoids, as well as monitoring delivery efficiency and intracellular trafficking.
RECAP: GENEGUT Seminar with Driton Vllasaliu, Engineered milk extracellular vesicles for oral delivery of RNA
RECAP: GENEGUT Seminar with Driton Vllasaliu, Engineered milk extracellular vesicles for oral delivery of RNA
New GENEGUT publication: Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease
We are happy to announce that our new GENEGUT publication “Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease” is now available to read online.
GENEGUT Seminar Series: Engineered milk extracellular vesicles for oral delivery of RNA | Dr. Driton Vllasaliu
We are excited to announce the first online seminar session in its upcoming series, featuring Dr. Driton Vllasaliu from King’s College London as a guest speaker. Dr. Vllasaliu will present
Patient stories: Over ten years to acceptance
I’ve lived with Crohn’s disease since I was nine years old, but it took me more than ten years to come to terms with my disease. At first, I was
UK participants in Horizon Europe Project GENEGUT are supported by UKRI grant number 10042451 (Bangor University).